The conference of the ‘Implantable Cardioverter Defibrillator for Life’ Initiative—Fighting
against Sudden Cardiac Death in Emerging Economies was jointly organized by the European
Heart Rhythm Association and the Hungarian Society of Cardiology.
The aim of the summit was to demonstrate the benefit and efficacy of the prevention
of sudden cardiac death (SCD). Sudden cardiac death is responsible for a significant
number of deaths at an annual level and it is the leading cause of death in industrial
countries. Many arrhythmias could be treated by means of device therapy and this would
also reduce the death rates. The target of the summit was to build bridges between
medical, political, and industrial sectors to procure greater political and economic
care and support for the primary and secondary prevention of sudden cardiac death,
heart failure, and arrhythmias.
The number of implantable cardioverter-defibrillator (ICD) implantations has increased
enormously in the recent years based on the proven efficacy of implantable devices
in the treatment of heart failure and heart rhythm disturbances. However, many patients
with high risk of SCD still do not undergo ICD implantation. The reason is partly
economic, and partly due to the lack of public awareness and the lack of qualified
specialists. The conference emphasized that both the theoretical background of device
therapy—professional recommendations, choice of implantable devices, programming,
and problem solving—and the practical education of implantation methods are important
to increase the implantation rates. The paradoxity of the effort to reduce SCD in
economies in transition is that there is a high prevalence of high-risk patients on
one side and actual implant rates both for primary and secondary prevention are disproportially
low.
The summit attempted to reflect regional disparities, their political, economic, financial,
and, last but not least, educational background through a series of lectures held
by the representatives of countries with low, medium, and, high implantation rates.
The importance of patient organizations was also emphasised; they may play a crucial
role in the improvement of patients’ quality of life, in risk reduction, and in prevention
of SCD in the European population. At the end of the sessions, Central-Eastern European
cardiologists, health-economists, politicians, and journalists discussed the reasons
for and the possible solutions to the regional differences within the roundtable discussions.
Acknowledging the importance, the timeliness and the message of the topic, Pál Schmitt,
President of the Hungarian Republic, and Miklós Réthelyi, Minister of National Resources,
undertook the main patronage of the event.
Invitation letters were sent to the presidents of all Cardiology Societies and Arrhythmia
Working Groups in the member states of ESC as well as to all decision-makers of EHRA
(Board Members and Committee Members). Finally, 197 registered participants from 31
countries arrived.
The programme of the Summit was arranged on the basis of the participants’ feedback;
also a teleconference with the leadership of EHRA was organized to discuss the key
points programme. The Faculty was composed of 55 renowned cardiologist-arrhythmologists,
health-economical, and political experts who represented 27 countries (Armenia, Belarus,
Belgium, Croatia, Czech Republic, Estonia, F.Y.R.O. Macedonia, Georgia, Germany, Greece,
Hungary, Israel, Italy, Latvia, Lebanon, Lithuania, Montenegro, Poland, Romania, Russia,
Serbia, Slovakia, Slovenia, Switzerland, Turkey, UK, and Ukraine) and acted as invited
chairs, and speakers in different sessions.
The event was preceded by a press conference with Prof. Panos Vardas, Prof. Béla Merkely,
Prof. Christian Wolpert, Prof. Goran Milasinovic, and Prof. Péter Józan. Based on
the number of participants, media journalists, and media appearances, the press conference
can be considered extremely successful.
Prof. Panos Vardas, the president of EHRA and the president-elect of the ESC, Prof.
Béla Merkely, the President of the Hungarian Society of Cardiology and the Co-chairman
of the National Societies Board of EHRA, and Ms Mária Sélleiné Márki, the Director
General of the National Health Insurance Fund of Hungary, opened the first session
of the event. Subsequently, speakers focused on the health care and health economical
differences among the European member states. In his talk, Prof. Péter Józan discussed
the cardiovascular epidemiological differences. Dr Péter Gaál explained the health
economical difficulties of the treatment of SCD. Prof. Stefan Kääb held a lecture
on the epidemiology of SCD and then Prof. Miran Kenda summarized the relationship
between diabetes and SCD. In the closing talk of the session, Prof. Christian Wolpert
reviewed the concept, the birth, and the development of the EHRA White Book, the annual
publication of the Association representing current status of cardiac electrophysiology
of the member states.
The second session was dedicated to the evidence on device therapy to fight SCD, both
in primary and secondary preventions. The reviews by Dr Zoltán Csanádi, Prof. Robert
Hatala, and Prof. Andrzej Lubinski covered the existing guidelines on ICD implants.
Prof. Milos Taborsky presented data obtained during the previous EHRA—Eastern Initiative
Meeting held in February 2010 in Pilsen. His lecture was followed by a roundtable
discussion.
In the third session on cardiac resynchronization therapy, Prof. Béla Merkely summarized
the latest evidence on efficacy of the treatment. On behalf of the National Health
Insurance Fund of Hungary, Dr József Gajdácsi explained the health economical background,
and the financial model of this special, expensive, but cost-effective treatment.
He presented the algorithms for decision making in Hungary.
In the fourth session, Prof. Frans Van de Werf focused on the process of establishment
and implementation of international guidelines. Then the lectures of Prof. John Camm
and Michael Glikson followed emphasizing the costs of ICD treatment and explaining
how the expenditure of the treatment influences the number of patients actually receiving
it. As implant rates of implantable devices depend also on the critical mass of available
specialists in each country, Prof. Josef Kautzner focused on the need for education
and outlined the policy of EHRA regarding the Central-Eastern European education in
arrhythmology.
In the next session, Prof. Davor Milicic and George Andrei Dan discussed complex questions
such as the treatment of SCD as a screen of patients with high-risk factors, the establishment
of proper predictive factors and their possible applications in clinical practice.
Prof. Alessandro Proclemer introduced a separate lecture on the Italian Pacemaker/ICD
registry. Follow-up data in this registry were considered very important. Prof. Amiran
Revishvili closed the session with a talk on ablation of ventricular tachycardias
and its importance in management of ICD patients with recurrent and frequent ventricular
arrhythmias.
The lectures in the last session dealt with the management of patients with an ICD
device and with the role of patient organizations in patient care. Dr Roland Dieckmann,
Ms Pavla Kristofova, and Ms Trudie Lobban presented the system and the achievements
of the German, Czech, and British models.
Ms Trudie Lobban highlighted that the British Arrhythmia Alliance-developed guidelines
and supported establishing a patient-focused arrhythmia organization, working in partnership
with clinicians. The organization offers website templates and other materials that
can be translated into the local language and they offer additional help to establish
local alliances. Besides, they can then help identify and train an administrator in
the country to move the organizations forward and raise awareness. More information
can be found at: www.heartrhythmcharity.org.uk/international-area. A new international
site was also launched in March 2011: www.afa-international.org and www.stars-international.org.
Finally, history, goals, and the planned future of the Eastern Initiative within the
EHRA were summarized by Prof. Goran Milasinovic. Prof. Karl-Heinz Kuck projected the
future perspectives of the treatment of SCD in Eastern Europe.
The participants had the opportunity to introduce the practice and data of their own
countries, and to reflect on their political-economic background in several roundtable
discussions. All the roundtable discussions were followed by presentation of a vision
of the future and the policy of the given treatment, previously discussed in the section.
As the site of the latest EHRA Summit, Hungary had been chosen by the European Society
of Cardiology as one of the countries where the number of implanted cardiac rhythm
management devices approaches the healthcare demands. Hungary is part of the ‘green
region’ of Eastern Europe where the number of implanted devices grows at an adequate
rate and there is an existing infrastructure for this therapy. As organizing the summit,
the Hungarian Society of Cardiology could introduce its decennial work, an exemplary
in the region.
The main message of the EHRA Summit was that the professional collaboration does not
suffice to remain within the country borders for the prevention of SCD. The collaboration
has to cross borders to develop unified international professional, health economical,
and health political strategy.
Therefore, the summit reached the consensus of creating a working board called ‘Working
Board of Eastern Initiative' (WBEA) within the EHRA, to delegate individual persons
for specific tasks. As Prof. Christian Wolpert and Prof. Panos Vardas supported the
idea, the WBEA was formed at the end of the summit. The members of the WBEA are Profs.
Christian Wolpert, Béla Merkely, Josef Kautzner, Goran Milasinovic, Robert Hatala,
George Andrei Dan, Milos Taborsky, and Zoltán Csanádi.
The tasks of this working board are the following: first, based on personal communication
with the cardiologist and arrhythmologist leaders of the specific region, Goran Milasinovic
will define and analyse the specific regional problems and obstacles in each country.
The analysis will detail the problems to be solved as to improve the efficacy of the
prevention of SCD (e.g. lack of well-trained experts and sufficient knowledge, lack
of referrals, infrastructural background, and reimbursement). The report will be sent
to WBEA to set the targets for the next 3 years to solve the most urgent problems
in each country. Secondly, WBEA will suggest specific education policy and establish
a list of training centres in the Eastern-European countries. Prof. Josef Kautzner
will be responsible for creating an educational plan for all regions and for defining
the rules and minimal requirements that have to be fulfilled by the Eastern European
training centres. Thirdly, to increase awareness of SCD among professionals and in
public, EHRA will help to organize lectures at national cardiology and arrhythmology
meetings in the region and promote the foundation of patient organizations. Fourthly,
together with the EHRA Board they will find the way to support the above educational
activities in Eastern Europe.
Faculty:
Angelo Auricchio (Switzerland)
Imre Benedek (Romania)
Tatsiana Burmistrava (Belarus)
John Camm (UK)
Zoltán Csanádi (Hungary)
George Andrei Dan (Romania)
Alexandru Deutsch (Romania)
Roland Dieckmann (Germany)
Dan Dobreanu (Romania)
Kakhaber Etsadashvili (Georgia)
Péter Gaál (Hungary)
József Gajdácsi (Hungary)
Nikola Gjorgov (F.Y.R.O. Macedonia)
Michael Glikson (Israel)
Robert Hatala (Slovakia)
Ashot Hovhannesyan (Armenia)
Charles Jazra (Lebanon)
Péter Józan (Hungary)
Stefan Kääb (Germany)
Oskars Kalejs (Latvia)
Josef Kautzner (Czech Republic)
Miran Kenda (Slovenia)
Pavla Kristofova (Czech Republic)
Karl-Heinz Kuck (Germany)
Andrzej Kutarski (Poland)
Trudie Lobban (UK)
Andrzej Lubinski (Poland)
Germanas Marinskis (Lithuania)
Béla Merkely (Hungary)
Goran Milasinovic (Serbia)
Davor Milicic (Croatia)
Przemyslaw Mitkowski (Poland)
Ljilja Music (Montenegro)
Ali Oto (Turkey)
Yulia Persidskikh (Belarus)
Alessandro Proclemer (Italy)
Amiran Revishvili (Russia)
Mária Sélleiné Márki (Hungary)
Milos Taborsky (Czech Republic)
Panos Vardas (Greece)
Radu Vatasescu (Romania)
Jüri Voitk (Estonia)
Dmitrij Volkov (Ukraine)
Frans Van de Werf (Belgium)
Christian Wolpert (Germany)
Funding
Funding to pay the Open Access publication charges was provided by the Hungarian Society
of Cardiology.